BioSpace News Archive

Genetown

Gatehouse Bio Announces Upcoming Presentation at RNA Leaders Europe Congress

Gatehouse Bio announced today that its Chief Executive Officer, David W. Salzman, PhD, will present at the upcoming RNA Leaders Europe Congress, in Basel, Switzerland on March 15, 2023 at 12:20PM CET.

March 13, 2023
·
2 min read
Business

VBI Vaccines Reports Full Year 2022 Financial Results

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the year ended December 31, 2022.

March 13, 2023
·
15 min read
Bio NC

Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS

Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral medications.

March 13, 2023
·
4 min read
Deals

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

Enochian BioSciences Inc. (the Company) announced that it has achieved full compliance with NASDAQ filing requirements.

March 13, 2023
·
1 min read
BioMidwest

Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging

Surgalign Holdings, Inc. is proud to announce the release of HOLO AI Insights.

March 13, 2023
·
7 min read
Business

Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia

Intelligent Bio Solutions Inc. today announced that the Company has selected Human and Supplement Testing Australia (“HASTA”).

March 13, 2023
·
4 min read
Biotech Bay

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank

Anixa Biosciences, Inc. today reassured its shareholders and the investment community that it does not have any accounts at recently collapsed Silicon Valley Bank.

March 13, 2023
·
1 min read
Drug Development

Remedium Bio announces publication of preclinical data demonstrating the safety and chondrogenic activity of RMD1101 in Cartilage

Remedium Bio today announced the publication of pre-clinical data demonstrating the safety and chondrogenic activity of RMD1101, its innovative gene therapy for Osteoarthritis.

March 13, 2023
·
2 min read
Biotech Bay

Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company’s FDA-Approved Prescription Drug

Jaguar Health, Inc. today announced that the Company is developing an artificial intelligence-powered web portal for U.S. healthcare professionals to support patient access to Mytesi.

March 13, 2023
·
5 min read
Business

Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023

Champions Oncology, Inc. will report its financial and operational results for the third quarter ended January 31, 2023, on Wednesday, March 15, 2023, after market close.

March 13, 2023
·
1 min read